FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

26 results

acthar
(Repository Corticotropin)
Mallinckrodt ARD LLC
Usage: Acthar Gel is indicated for treating infantile spasms in infants, acute exacerbations of multiple sclerosis in adults, and various rheumatic disorders. It is also used for collagen diseases, severe dermatologic conditions, allergic states, specific ophthalmic and respiratory diseases, and to manage proteinuria in nephrotic syndrome.
adempas
(riociguat)
Bayer HealthCare Pharmaceuticals Inc.
Usage: Adempas is indicated for adults with chronic thromboembolic pulmonary hypertension (CTEPH) after surgical treatment or if inoperable, as well as for pulmonary arterial hypertension (PAH). It improves exercise capacity, WHO functional class, and delays clinical worsening. The drug is effective as monotherapy or in combination with other treatments.
advair
(fluticasone propionate and salmeterol)
GlaxoSmithKline LLC
Usage: ADVAIR DISKUS is indicated for the twice-daily treatment of asthma in patients aged 4 and older and for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for acute bronchospasm relief or for patients not adequately controlled on long-term asthma medications.
alvesco
(ciclesonide)
Covis Pharma US, Inc
Usage: ALVESCO is indicated for the maintenance treatment of asthma in adults and pediatric patients aged 12 and older. It is not intended for the relief of acute bronchospasm or for children under 12 years of age.
anoro ellipta
(umeclidinium bromide and vilanterol trifenatate)
GlaxoSmithKline LLC
Usage: ANORO ELLIPTA is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or asthma treatment, and its safety and effectiveness in asthma have not been established.
arnuity ellipta
(fluticasone furoate)
GlaxoSmithKline LLC
Usage: ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adults and children aged 5 years and older, but is not intended for the relief of acute bronchospasm.
avycaz
(ceftazidime, avibactam)
Allergan, Inc.
Usage: AVYCAZ (ceftazidime and avibactam) is indicated for treating complicated intra-abdominal and urinary tract infections, including pyelonephritis, as well as hospital-acquired and ventilator-associated bacterial pneumonia. It targets susceptible gram-negative bacteria in adult and pediatric patients (≥31 weeks gestational age).
cinqair
(Reslizumab)
Teva Respiratory, LLC
Usage: CINQAIR® is indicated as an add-on maintenance treatment for adults (18+) with severe asthma exhibiting an eosinophilic phenotype. It is not intended for other eosinophilic conditions or for acute bronchospasm relief or status asthmaticus.
cytalux
(Pafolacianine injection)
On Target Laboratories, Inc.
Usage: CYTALUX is indicated as an adjunct for intraoperative identification of malignant lesions in adult patients with ovarian cancer and for both malignant and non-malignant pulmonary lesions in adult patients with known or suspected lung cancer.
dupixent
(Dupilumab)
sanofi-aventis U.S. LLC
Usage: DUPIXENT is indicated for treating moderate-to-severe atopic dermatitis in patients 6 months and older, asthma in patients 6 years and older, chronic rhinosinusitis with nasal polyps in patients 12 and older, eosinophilic esophagitis, prurigo nodularis, inadequate COPD management, chronic spontaneous urticaria over 12, and bullous pemphigoid in adults.

Pulmonology drugs

acthar

adempas

advair

alvesco

anoro ellipta

arnuity ellipta

avycaz

cinqair

cytalux

dupixent